Vince & Associates Clinical Research, Overland Park, Kan., has opened a 90-bed Clinical Pharmacology Research Unit designed as a boutique hotel experience for the study volunteers and a first class scientific research setting for the biopharmaceutical industry, according to a company statement.
Amenities include bedside 20-inch touch screen entertainment systems, in-house theater room, and individually themed luxury suites. Subject safety and security measures are coupled with a Physician Research Model where principal investigators lead and are involved in all aspects of ongoing clinical studies.
“The unit is purpose-built for the complex trials our clients require to make earlier drug development decisions and advance their drugs to market more aggressively than ever before. For example, we provide the full technical resources and medical expertise required for Phase I/IIa Proof of Concept (POC) studies which incorporate a single ascending dose (SAD), multiple ascending dose (MAD) and a patient proof of concept study into a single protocol,” says Dr. Brad Vince, president and medical director of Vince & Associates Clinical Research.
The facilities include a USP 797-compliant bio-safety cabinet and full time pharmacy staff, which allows for sterile preparation. The client’s API can be compounded on site or drugs can be prepared extemporaneously. The facility includes laboratory areas for the processing of biomarkers and blood samples and for specialized testing.

Release Date: April 2, 2011
Source: Vince and Associates Clinical Research